Ekso Bionics to Participate at the 15th Annual Craig-Hallum Alpha Select Conference

Company Overview - Ekso Bionics Holdings, Inc. is a leader in exoskeleton technology for both medical and industrial applications [3] - The company was founded in 2005 and is headquartered in the San Francisco Bay Area [3] - Ekso Bionics is publicly traded on the Nasdaq Capital Market under the symbol "EKSO" [3] Recent Developments - The CEO Scott Davis and CFO Jerome Wong will participate in the 15th Annual Craig-Hallum Alpha Select Conference in New York on November 19, 2024 [1] - Management will also engage in one-on-one meetings with institutional investors during the conference [2] Product and Technology - Ekso Bionics develops exoskeleton solutions that enhance human strength, endurance, and mobility [3] - The company offers technologies that assist individuals with paralysis to stand and walk, as well as enhance capabilities in various job sites globally [3]